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MDR1 P-Glycoprotein Is a Lipid Translocase
of Broad Specificity, While MDR3 P-Glycoprotein
Specifically Translocates Phosphatidylcholine
Ardy van Helvoort,* Alexander J. Smith,† diffuse from the cell surface into the extracellular me-
dium, the “flippase” action of MDR1 Pgp would effectHein Sprong,* Ingo Fritzsche,*‡
a net removal of the substrate from thecytoplasm. UsingAlfred H. Schinkel,† Piet Borst,†
ATP, the MDR1 Pgp can pump drugs against a concen-and Gerrit van Meer*
tration gradient, which in the flippase model is a gradient*Department of Cell Biology
between the cytoplasmic and exoplasmic leaflet of theFaculty of Medicine and Institute of Biomembranes
plasma membrane lipid bilayer.Universiteit Utrecht
No drug-pumping activity has been demonstrated3584 CX Utrecht
thus far for the MDR3 Pgp (Gros and Buschman, 1993),The Netherlands
which is highly homologous with MDR1 Pgp (van der†The Netherlands Cancer Institute
Bliek et al., 1988). Human MDR3 and mouse mdr2 PgpPlesmanlaan 121
are present in high concentrations in the bile canalicular1066 CX Amsterdam
membrane. Homozygous disruption of the murine mdr2The Netherlands
gene led to a complete absence of phospholipid from
the bile (Smit et al., 1993), and MDR3 Pgp can function-
ally replace mdr2 Pgp in knock-out mice (A. Smith, P.Summary
Borst, and R. Oude Elferink, unpublished data). This has
led to the suggestion that mdr2 and MDR3 Pgp mayThe human MDR1 P-glycoprotein (Pgp) extrudes a va-
translocate the membrane phospholipid phosphatidyl-riety of drugs across the plasma membrane. The ho-
choline (PC) towards the outer bilayer leaflet of themologous MDR3 Pgp is required for phosphatidylcho-
plasma membrane. Subsequently, it was concludedline secretion into bile. After stable transfection of
from experiments on membranes from yeast expressingepithelial LLC-PK1 cells, MDR1 and MDR3 Pgp were
the mdr2 gene that mdr2 Pgp can translocate a PC withlocalized in the apical membrane. At 158C, newly syn-
a short acyl chain and a fluorescent aromatic group inthesized short-chain analogs of various membrane lip-
the 2-position of the glycerol, C6-NBD-PC (N-6[7-nitro-ids were recovered in the apical albumin-containing
2,1,3-benzoxadiazol-4-yl]-amino-hexanoyl- phosphati-medium of MDR1 cells but not control cells. MDR in-
dylcholine), from the cytosolic leaflet to the exoplasmichibitors and energy depletion reduced apical release.
leaflet of the lipid bilayer. The mouse homolog of humanMDR3 cells exclusively released a short-chain phos-
MDR1 Pgp, mdr1a Pgp (nomenclature as in Smit et al.phatidylcholine. Since no vesicular secretion occurs
[1994]), did not translocate C6-NBD-PC in these experi-at 158C, the short-chain lipids must have been translo-
ments (Ruetz and Gros, 1994, 1995). Direct evidencecated by the Pgps across the plasma membrane be-
that MDR3 Pgp can translocate endogenous PC hasfore extraction into the medium by the lipid-acceptor
been obtained in fibroblasts from transgenic mice ex-albumin.
pressing the MDR3 gene, where [3H]choline-labeled PC
became more rapidly accessible on the cell surface than
in control fibroblasts (Smith et al., 1994).Introduction
In the present study, we have made stable transfec-
tants of pig kidney epithelial (LLC-PK1) cells containing
The human multidrug resistance MDR1 and MDR3
human MDR1 or MDR3 Pgp or mouse mdr1a Pgp and
P-glycoproteins (Pgps) belong to the ubiquitous family
devised an assay to test whether the Pgps are capable
of membrane transporters that contain an ATP-binding of translocating membrane lipids from the cytosolic side
cassette (ABC–transporters) and consume ATP during
to the exoplasmic leaflet of the plasma membrane. For
translocation of a wide variety of molecules from the
this, we have made use of observations by Pagano et
cytosol to the extracellular space (Higgins, 1992; Gottes-
al. (1981; Lipsky and Pagano, 1985) that diacylglycerol
man and Pastan, 1993; Gros and Buschman, 1993). The with a short fluorescent acyl chain at the sn-2 position
MDR1 Pgp is expressed in the apical membrane of many (C6-NBD-diacylglycerol) is efficiently converted by cellsepithelial and endothelial cells, but it also occurs at the to the homologous PC (C6-NBD-PC) and phosphati-
surface of many tumor cells. It has beenfound toextrude dylethanolamine (C6-NBD-PE), while C6-NBD-ceramide
multiple drugs from the cell that have little in common yields the corresponding sphingomyelin (C6-NBD-SM)
but an amphipathic structure. One model for its mecha- and glucosylceramide (C6-NBD-GlcCer). Synthesis of
nism of action proposes that MDR1 Pgpbinds an amphi- PC, PE, and GlcCer occurs on the cytosolic surface of
pathic molecule in the cytoplasmic leaflet of the plasma the endoplasmic reticulum (ER) and Golgi apparatus
membrane and flips its polar group across the plasma (Kent, 1995; Burger et al., 1996). Because of their short
membrane to deliver the molecule to the exoplasmic acyl chain, the C6-NBD-analogs of these lipids can freely
leaflet of the plasma membrane (Higgins and Gottes- exchange as monomers through the cytosol between
man, 1992). Since the amphipathic molecule can now their site of synthesis and the inner leaflet of the plasma
membrane, possibly assisted by lipid transfer proteins.
Translocation across the plasma membrane to its exo-‡Permanent address: Department of Neonatology, University Chil-
plasmic leaflet, the cell surface, can be measured bydren’s Hospital, Charite´, Humboldt University–Berlin, Berlin, Federal
Republic of Germany. extracting short-chain lipids from the cell surface into
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Figure 1. Immunolocalization of MDR3 Pgp
in Transfected LLC-PK1 Cells by Confocal
Laser Scanning Microscopy
Indirect immunofluorescence (FITC) picture
with the anti-Pgp monoclonal antibody C219
on LLC-M3.4.44 cells is shown in green and
nuclear counterstaining with propidium io-
dide in red.
(A) Top view of the cell layer. Bar, 25 mm.
(B) Optical sections perpendicular to the
plane of the cell layer. Upper and lowerarrow-
heads in (A) indicate the positions of the re-
spective sections in (B).
medium containing excess albumin, a protein that binds and of the murine mdr1a Pgp in these cell lines (data
not shown). The correct localization of MDR3 Pgp inshort-chain lipids and in this case acts as a sink.
Throughout the experiments with monolayers of LLC- the apical membrane of the transfected cell line LLC-
M3.4.44 was verified in cells on filters by confocal laserPK1 cells, the apical medium remains separated from
the basolateral medium underneath the filter because scanning microscopy, using the Pgp-specific mono-
clonal antibody C219 (Georges et al., 1990). Approxi-of the presence of tight junctions between the cells (van
Meer et al., 1987; Schinkel et al., 1995). Arrival of lipids mately half of the cells displayed strong but heteroge-
neous staining (Figure 1). With MDR3-specific polyclonalat the cell surface by the processes of exchange and
translocation can be discriminated from delivery to the antiserum a-REG1, identical results were obtained (data
not shown). A perpendicular view of the cells confirmedcell surface in membrane vesicles by lowering the tem-
perature to 158C, at which point vesicular lipid transport that the MDR3 Pgp was exclusively localized apically
(Figure 1B). No staining was observed in the un-is blocked (van Genderen and van Meer, 1995).
Indications for lipid translocation activity of the MDR transfected cells (data not shown).
In the LLC-PK1 cells transfected with MDR1 andPgps would be as follows: first, increased depletion of
C6-NBD-lipids into the medium from transfectedas com- mdr1a constructs, the Pgp activity has been localized
in the apicalmembrane (Schinkel et al.,1995). Virtually allpared with control cells; second, confinement of the
difference to the apical cell surface where MDR Pgps cells were positive for the Pgp by immunofluorescence
(data not shown).are localized; third, sensitivity of the difference to typical
MDR inhibitors and energy depletion; and fourth, speci-
ficity for defined lipid classes or species. As expected Apical Translocation of C6-NBD-PC by
MDR3-Expressing LLC-PK1 Cells and(Ruetz and Gros, 1994), MDR3 Pgp fulfilled all criteria
and translocated C6-NBD-PC but not the other lipids. of C6-NBD-PC and C6-NBD-PE
by MDR1-Expressing CellsUnexpectedly, human MDR1 and mouse mdr1a Pgpmet
the first through third requirements and translocated all To generate C6-NBD-PC and -PE in the cytosol, we incu-
bated confluent monolayers of LLC-PK1 cells and MDRlipids tested. We conclude that MDR1 and mdr1a Pgp
may have a physiological function as flippases in trans- transfectants with C6-NBD-PA complexed to bovine se-
rum albumin (BSA) for 3 hr at 158C (Pagano et al., 1981;locating certain types of lipid molecules across the
plasma membrane. van Helvoort et al., 1994). A small fraction of C6-NBD-
PA partitions into the plasma membrane and is de-
phosphorylated to C6-NBD-diacylglycerol. Owing to the
absence of a polar headgroup, this molecule can trans-Results
locate across the plasma membrane and by monomeric
exchange reach the choline- and ethanolaminephos-Expression of Pgps in Transfected LLC-PK1 Cells
A protein blot analysis of Pgps in the cell line LLC-PK1 photransferase, probably at the ER, by which it is con-
verted to C6-NBD-PC and -PE even at 158C (Figure 2).and the MDR1-, MDR3-, and mdr1a-transfected clones
(as in Schinkel et al. [1995]) demonstrated comparable After 3 hr, only a small fraction of each lipid was found
in the apical BSA medium of the control cells. Becauselevels of expression of the human MDR1 and MDR3 Pgp
Lipid Translocation by MDR1 Pgp
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Figure 2. Translocation of C6-NBD-Phos-
pholipids across the Apical Plasma Mem-
brane of MDR-Transfected LLC-PK1 Cells
Cell monolayers were incubated with 25 mM
C6-NBD-PA on both sides for 3 hr at 158C.
Fluorescent lipid products, C6-NBD-PC (light
bars) and C6-NBD-PE (dark bars), appearing
at the cell surface, were depleted into the
BSA–containing medium. In the experiments
in (B) and (D), the incubation was performed
in the presence of [3H]choline, and the avail-
ability of C6-NBD-[3H]PC for BSA depletion
was assessed. Top panels illustrate TLC sep-
aration (10 3 20 cm2) of cell lipids. O, origin;
bar, 1 cm. C6-NBD-diacyl- and triacylglycerol
at the solvent frontare not shown.Media con-
tained much more C6-NBD-PA but essentially
no [3H]PC. Lipids were quantitated as de-
scribed in Experimental Procedures. Synthe-
sis from 75 nmol C6-NBD-PA was typically 15
pmol C6-NBD-PC and 10 pmol C6-NBD-PE
per filter for all cells. Data in (A) and (C) are
the mean of five independent experiments in
duplicate (plus or minus standard deviation;
n 5 10). In (B) and (D), [3H]choline incorpora-
tion in MDR1, control, and MDR3 cells into
C6-NBD-PC was 4 3, 2 3, and 1.5 3 103 dpm,
while [3H]PC contained 5 3, 3.5 3, and 2 3
105 dpm, respectively. Data are the mean of
two experiments plus or minus difference
from the mean. The structure formulas in the
various figures (see Pascher, 1976) illustrate
the position and length of the chains. B, base,
choline in PC or ethanolamine in PE; NBD,
fluorescent group; P, phosphate; asterisk,
[3H]radiolabel; “5 O” and “2OH” have been
omitted for clarity.
extraction from the membrane by BSA occurs down to shows that the C6-NBD-PC on the basolateral surface
is not derived from the intracellular pool but reflects C6-08C (van Meer et al., 1987), this shows that transport to
the cell surface is blocked at 158C. Surprisingly, 20%– NBD-PC synthesis on the basolateral cell surface, most
likely by a sphingomyelin synthase (van Helvoort et al.,25% of both C6-NBD-PC and -PE was found in the apical
medium of MDR1-transfected cells, which suggests that 1994). In contrast, the C6-NBD-PC in the apical media
was [3H]-labeled, so it was derived from the intracellularMDR1 Pgp can translocate both C6-NBD-PC and -PE
across the apicalmembrane (Figure 2A). A portion (18%) C6-NBD-PC. This confirms the selective translocation of
C6-NBD-PC across the apical plasma membrane of bothof the C6-NBD-PC but essentially no C6-NBD-PE was
recovered from the apical medium of the MDR3- MDR transfectants (Figure 2B). Also, the basolateral me-
dium of the MDR1 cells contained more C6-NBD-[3H]PCtransfected cells (Figure 2A), in line with a translocator
activity for the MDR3 Pgp that is specific for C6-NBD- than that of untransfected cells. This may reflect the
presence of some MDR1 Pgp at the basolateral surfacePC as observed for the murine mdr2 Pgp (Ruetz and
Gros, 1994, 1995). The lower level of transport of C6- of MDR1 cells (see below).
Owing to the continuous presence of precursor, syn-NBD-PC in the MDR3-transfected cells compared with
the MDR1-transfectant will be due (partly) to the fact thesis of C6-NBD-PC and -PE in MDR1 cells was linear
with time for the first 5 hr at 158C. The appearance ofthat approximately half of the MDR3 cells do not contain
the Pgp (Figure 1), whereas the MDR1 cell line has a the lipids in the apical medium displayed a lag. After 2
hr, 12% of the C6-NBD-PC and 19% of the C6-NBD-PEmore homogeneous expression.
A significant amount of C6-NBD-PC was found in the was found in the apical medium, increasing to 25% for
each lipid after 3 hr. Between 3 and 5 hr, the amount inbasolateral medium of all cells (Figure 2C). However,
when the incubation was performed in the presence of the medium increased linearly in parallelwith the synthe-
sis, still equaling 25% after 5 hr. The same was observed[3H]choline, virtually no C6-NBD-[3H]PC was found in the
basolateral medium of control cells (Figure 2D). This for C6-NBD-PC in MDR3 cells, with 10% in the apical
Cell
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Table 1. Inhibition of the Appearance of C6-NBD-PC and C6-NBD-PE in the Apical Medium of MDR1-Transfected Cells by Verapamil
and Energy Depletion
C6-NBD-PC (% of total in apical medium) C6-NBD-PE (% of total in apical medium)
LLC-PK1 cells Untreated 1 Verapamil (20 mM) Energy depleted Untreated 1 Verapamil (20 mM) Energy depleted
MDR1 20.3 6 4.1 6.7 6 1.7 4.5 6 3.9 21.3 6 8.5 2.6 6 1.5 3.7 6 5.2
Control 4.5 6 1.9 6.1 6 1.1 6.3 6 6.9 2.0 6 1.5 0.4 6 0.3 ND
MDR3 18.1 6 3.8 6.0 6 3.8 10.4 6 0.2 4.2 6 2.8 1.1 6 1.1 ND
After a preincubation of 10 min at 378C with 20 mM verapamil or in PBS plus 2 mM NaN3 plus 50 nM deoxyglucose plus 2 mM KCN plus 20
mM KF, cell monolayers were incubated with 25 mM C6-NBD-PA on both sides for 3 hr at 158C in the presence of the inhibitors. Synthesis of
C6-NBD-PC was 1.0 6 0.2 3 control after verapamil and 0.6 6 0.1 3 control after energy depletion; for C6-NBD-PE, this was 1.4 6 0.3 3 and
0.1 6 0.1 3 control, respectively, for all three cell lines. The quantity of C6-NBD-PC in the basolateral medium was not reduced (less than
90% of control). Data are the mean of two independent experiments in duplicate and are followed by the standard deviation (n 5 4). ND:
could not be measured reliably because of reduced synthesis.
medium after 2 hr and 15% after 3 and 5 hr. The small ing the NBD moiety. Short chains were required for the
percentage of C6-NBD-PC and -PE in the apical medium use of BSA depletion as a translocation assay. When
of control cells, of C6-NBD-PE in the apical medium of cells were incubated with C8C8-PA and [3H]choline for 3
MDR3 cells, and of C6-NBD-PE in the basolateral media hr at 158C, three products were formed. One of these
of all cells displayed no lag. It was identical after 2, comigrated with natural PC, a second with C8C8-PC, and
3, and 5 hr, as was basolateral C6-NBD-PC. The 3 hr a third migrated in between the others (Figure 3). The
timepoint reliably indicated the differences in transloca- latter PC most likely originated from a reacylation event
tion capacity of the cells and was selected for further in which one C8 chain of C8C8-PC had been exchanged
experiments. for a C16 or C18 chain; when cells were incubated with
C8C8-PA and [14C]C18:1, the two [14C]products colocalized
Apical Translocation of C6-NBD-PC and C6-NBD-PE with natural PC and with the intermediate band (data
Is Sensitive to the MDR Inhibitor Verapamil not shown). To focus on the original product, reacylation
and to Energy Depletion was inhibited by the serine-esterase inhibitor phenyl-
As a direct test for a functional involvement of MDR1 methanesulfonyl fluoride, which in the concentration
and MDR3 Pgps in the appearance of C6-NBD-PC and used (0.2 mM) had no effect on transport of C6-NBD-PC
-PE in the apical medium of the transfectants, we incu- into the apical medium of MDR transfectants. Efficient
bated the cells with C6-NBD-PA in the presence and transport of C8C8-[3H]PC was observed into the apical
absence of verapamil, an inhibitor of the action of MDR1 medium of MDR1 cells (28 6 6%; n 5 5), while only a
(Gottesman and Pastan, 1993) and MDR3 Pgp (Ruetz small amount (9 6 1%) was found in the basolateral
and Gros, 1994). Verapamil reduced the fraction of C6- medium and in the media of control cells (apical: 3.5 6
NBD-PC and -PE in the apical medium of MDR1 cells 0.3%; basolateral: 6 6 3%). Remarkably, little transport
to 33% and 12% of the control value, respectively, while of C8C8-[3H]PC was observed to the apical medium of
the fraction of C6-NBD-PC in the medium of MDR3 cells MDR3 cells (6 6 2%; basolateral 5 6 1%).
was reduced to 33% of the control (Table 1). Similar Incubation of cells with C8C8-PA and [14C]ethanolam-results were obtained on [3H]choline-labeled C6-NBD- ine resulted in the production of three [14C]products. As
PC (data not shown). Verapamil had no effect on the
in the case of C8C8-PC, these represented natural PE,presence of C6-NBD-PC in the basolateral medium, as C8C8-PE, and reacylated C8C8-PE. The addition of phen-expected for PC synthesized by an energy-independent
ylmethanesulfonyl fluoride resulted in the production of
headgroup transfer at the cell surface (see above). To
appreciable amounts of C8C8-[14C]PE. Like C8C8-[3H]PC,assess whether the presence of C6-NBD-PC and -PE in C8C8-[14C]PE was selectively recovered from the apicalthe apical medium was a consequence of active trans-
medium of MDR1 cells (12 6 1%; n 5 4) and not controlport, we subjected cells to energy depletion before incu-
(2 6 1%)or MDR3 cells (2 6 1%),nor from thebasolateralbation with C6-NBD-PA. Indeed, besides a reduced syn-
media (2 6 1% in all cells), demonstrating the abilitythesis, such treatment resulted in a dramatic decrease
of MDR1 Pgp to translocate phospholipids with shortin the fraction of both NBD products in the apical me-
chains but lacking the NBD moiety (Figure 3).dium of MDR1 cells (Table 1). In MDR3 cells, energy
depletion had less effect on the amount of apical C6-
NBD-PC (240%). This possibly reflects the partial open-
Apical Translocation of C6-NBD-SM anding of the tight junctions,measured as a drop inelectrical
C6-NBD-GlcCer by MDR1-Expressing Cellsresistance (data not shown), by which some C6-NBD-
and Not by MDR3-Expressing CellsPC synthesized on the basolateral surface (see Figure 1)
To study the backbone specificity of MDR1 and MDR3became available apically, masking the effect of energy
Pgp, we incubated the cells with C6-NBD-ceramide todepletion.
synthesize the sphingolipids sphingomyelin (SM), which
has the same phosphocholine headgroup as PC butApical Translocation of C8C8-PC and C8C8-PE
a ceramide backbone instead of a diacylglycerol, andby MDR1-Expressing LLC-PK1 Cells But
glucosylceramide (GlcCer). C6-NBD-SM is synthesizedNot by MDR3-Expressing Cells
in the lumen of theGolgi buthas no access to the cytosolTo characterize further lipid translocation by MDR1 and
MDR3 Pgp, we studied the behavior of PC and PE lack- and reaches the cell surface by vesicular traffic but not
Lipid Translocation by MDR1 Pgp
511
Figure 3. Translocation of C8C8-[3H]PC and
C8C8-[14C]PE across the Apical Plasma Mem-
brane of MDR1-Transfected Cells
After a choline/ethanolamine depletion in
HBSS for 1 hr at 378C, cells were preincu-
bated with [3H]choline (A) or [14C]ethanolam-
ine (B) for another 1 hr at 378C, after which
C8C8-PA (50 mM) and 0.2 mM phenylmeth-
anesulfonyl fluoride were added to the media.
After 3 hr at 158C, lipids from media and cells
were extracted and separated by one-dimen-
sional TLC, all as described in Experimental
Procedures. Lanes A, apical medium; lanes
B, basolateral medium; lanes C, cells. Incor-
poration of radiolabel in MDR1, control, and
MDR3 cells, respectively: [3H]PC: 8 3, 3 3,
and 1 3 105 dpm; C8C8-PC 10% of the natural
PC in each cell line; [14C]PE: 4 3, 6 3, and 2
3 104 dpm; C8C8-PE 5% of the natural PE in
each cell line. Structure (C): B, choline in PC
or ethanolamine in PE; P, phosphate; aster-
isk, [3H]radiolabel in PC or [14C]radiolabel
in PE.
at 158C (van Genderen and van Meer, 1995). No C6-NBD- A functional involvement of MDR1 Pgp in apical trans-
location of C6-NBD-GlcCer at 158C was confirmed bySM was found in the apical media. In contrast, C6-NBD-
GlcCer, like PC and PE, is synthesized on the cytosolic the effect of the MDR inhibitors verapamil and PSC 833.
While verapamil reduced apical transport by 75%, trans-surface of an intracellular membrane, in this case the
Golgi, from where it can freely equilibrate with the inner port was virtually blocked by PSC 833. Also, energy
depletion efficiently inhibited transport (Figure 5).leaflet of the plasma membrane owing to its short chain
(see Burger et al., 1996). C6-NBD-GlcCer was found in
the apical medium of MDR1 cells exclusively (Figure 4A). Apical Translocation of C6-GlcCer and C8C8-GlcCer
by MDR1- But Not MDR3-Expressing CellsAt temperatures greater than or equal to 208C, signifi-
cant amounts of both C6-NBD-GlcCer and -SM ap- To demonstrate that the NBD moiety was not essential
for translocation of GlcCer, cells were incubated withpeared in apical and basolateral media owing to the
contribution of vesicular membrane transport (data not [14C]C6-ceramide or [3H]C8C8-ceramide. Synthesis of
short-chain GlcCer and SM and distribution over cellsshown; see van Genderen and van Meer, 1995).
The situation was different when the cells were pre- and media were measured after 3 hr at 158C (Figure 6).
Indeed, both types of GlcCer were translocated into thetreated with brefeldin A. Now, not only C6-NBD-GlcCer
but also C6-NBD-SM was recovered from the apical me- apical medium of MDR1 cells but not of control or MDR3
cells (data not shown). The corresponding SMs weredium of MDR1 cells (Figure 4B). Brefeldin A has been
shown to induce retrograde transport of Golgi enzymes not recovered in any of the apical media, in line with the
observation that SM after synthesis in the lumen of theto the ER (Klausner et al., 1992), where lumenal lipids
have access to the cytosolic side (see Burger et al., Golgi has no access to the cytosolic surface of the Golgi
(see above). The fact that some basolateral transport of1996; Buton et al., 1996). The selective translocation of
C6-NBD-SM into the apical medium of MDR1 cells (and C6-NBD-[3H]PC and the various GlcCers was observed
in cells transfected with MDR1, and that it was sensitivenot MDR3 cells) demonstrates that C6-NBD-SM in the
presence of brefeldin A had access to the cytosolic to PSC 833, suggests that some MDR1 Pgp molecules
were present on the basolateral surface.surface of the plasma membrane and cannot be translo-
cated by MDR3 Pgp. The C6-NBD-SM in the basolateral A much larger fraction of C8C8-GlcCer than of C6-
GlcCer was recovered in the 158C medium. This proba-medium of all cells most likely originated from the action
of an SM synthase on the basolateral cell surface (van bly reflects the fact that the former analog owing to its
two short chains is essentially water-soluble (Karren-Helvoort et al., 1994), the presence of which was evident
from the production of C6-NBD-PC but not -PE on the bauer et al., 1990) and after synthesis has more rapid
access to the inside of the plasma membrane.basolateral surface (see Figure 2).
Cell
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Figure 4. Translocation of C6-NBD-SM and C6-NBD-GlcCer across the Apical Plasma Membrane of MDR1-Transfected Cells
Cells were incubated with 5 mM C6-NBD-ceramide for 3 hr at 158C, after which C6-NBD-GlcCer (shaded bars) and C6-NBD-SM (solid bars) in
cells and media were quantitatively analyzed as described in Experimental Procedures. In (B) and (D), cells were pretreated with 1 mg/ml of
brefeldin A for 30 min at 378C, after which the incubation at 158C was carried out in the presence of brefeldin A. Synthesis in (A) and (C) was
68 6 16 pmol (n 5 30) for C6-NBD-GlcCer and 153 6 29 pmol (n 5 30) for C6-NBD-SM per filter for all three cell lines. Data are the mean of
five independent experiments in duplicate (plus or minus standard deviation; n 5 10). Synthesis of C6-NBD-GlcCer was not affected by
brefeldin A, whereas C6-NBD-SM synthesis increased two to four times. Data in (B) and (D) are the mean of two independent experiments in
duplicate (plus or minus standard deviation; n 5 4). Structure: B, choline in SM; G, glucose in GlcCer; NBD, fluorescent group; P, phosphate.
A Mouse Homolog of Human MDR1 Pgp, centration of BSA needed to complex the ceramide
mdr1a Pgp, Translocates C6-NBD-PC, (0.03%; w/v), after 3 hr at 158C the apical medium of the
-PE, -GlcCer, and -SM MDR1 cells contained 7 6 1% of the C6-NBD-GlcCer.
Evidence has been presented suggesting that mouse Subsequently, two washes for 30 min on ice with 1%
mdr1a Pgp, in contrast to mouse mdr2 Pgp, cannot BSA released an additional 31 6 3% of the total C6-
translocate C6-NBD-PC across the membrane (Ruetz NBD-GlcCer. If BSA was present in the 158C incubation
and Gros, 1994). Since these Pgps are the homologs of medium (compare with Figure 4), this contained 92 6
the human MDR1 and MDR3 Pgp, respectively (see Smit 3% (n 5 2) of the total amount of C6-NBD-GlcCer that
et al., 1994), and since MDR1 Pgp does translocate C6- was recovered in incubation medium plus washes. As
NBD-PC, we tested the translocation activity of mdr1a expected (see Figure 4), the combined media and
Pgp in mdr1a-transfected LLC-PK1 cells. When thecells washes from MDR3 cells contained only 5 6 1% of the
were incubated with C6-NBD-PA or -ceramide for 3 hr total C6-NBD-GlcCer. Of the C6-NBD-SM, 2 6 1% was
at 158C, a large fraction of the C6-NBD-PC, -PE, and found in the combined apical media and 8 6 1% in the
-GlcCer, but not of the C6-NBD-SM, was recovered in combined basolateral media of both cell types (n 5 4).
the apical medium (Figure 7). Except for the PC (surface Obviously, in MDR1 cells, 30%–40% of total C6-NBD-
synthesis), only small amounts were found in the baso- GlcCer had been translocated to the outer leaflet of the
lateral medium. In cells treated with brefeldin A, C6-NBD- apical plasma membrane during 3 hr at 158C, to be
SM also appeared in the apical medium. We conclude released into the medium only in the presence of BSA.
that mdr1a Pgp expressed at the same level as MDR1 This experiment demonstrates that a substrate translo-
Pgp displays a comparable lipid translocation activity. cated by MDR1 Pgp indeed accumulates in the outer
It is unclear why Ruetz and Gros (1994) did not observe leaflet of the plasma membrane.
translocation of C6-NBD-PC in their experimental
system.
Discussion
In the Absence of BSA, MDR1 Pgp Translocates
Human MDR3 Pgp, a PC TranslocaseC6-NBD-GlcCer to the Outer Leaflet
After the original suggestion that the function of theof the Plasma Membrane Bilayer
mouse mdr2 Pgp in the bile canalicular membrane mightWhen MDR1 cells and MDR3 cells were incubated with
C6-NBD-ceramide in the presence of the minimal con- be translocation of PC across the plasma membrane to
Lipid Translocation by MDR1 Pgp
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Human MDR1 Pgp and Mouse mdr1a Pgp,
Broad-Specificity Lipid Translocases
Surprisingly, MDR1 and mdr1a Pgps are as efficient as
MDR3 Pgp in translocating C6-NBD-PC across theapical
surface (Figures 2 and 7). This is in conflict with the
conclusion by Ruetz and Gros (1994) from a different
assay system in which mdr1a (termed Mdr3) Pgp ex-
pressed in yeast secretory vesicles did not translocate
NBD-PC. The reason for this is unclear.
Translocation by MDR1 and mdr1a Pgpwas not selec-
tive, since C6-NBD-PE, -GlcCer, and -SM were translo-
cated as well (Figures 4 and 7). MDR1 Pgp also translo-
cated the more natural versions of these lipids lacking
the NBD moiety (Figures 3 and 6). First of all, this finding
has implications for the mechanism of action of MDR1
Pgp. Since the concentration of the C6-NBD-lipids in the
aqueous phase is low, the fact that they are a substrate
for the MDR1 Pgp suggests that they were able to reach
the substrate binding site from within the membrane.
In the absence of a suitable acceptor, C6-NBD-GlcCer
ended up in the outer leaflet of the plasma membrane
of MDR1 cells (see Results), suggesting a lipid flippase
Figure 5. Inhibition of the Appearance of C6-NBD-GlcCer in the Api- action of the MDR1 Pgp (see Devaux and Zachowski,
cal Medium of MDR1-Transfected Cells by MDR Inhibitors and En- 1994). This provides support for the flippase hypothesis
ergy Depletion
for the mechanism of the multidrug transport by the
MDR1 cells were incubated with 5 mM C6-NBD-ceramide under the MDR1 Pgp (Higgins and Gottesman, 1992).
conditions for inhibition of MDR1 Pgp or for energy depletion de-
scribed in the legend to Table 1. The concentration of PSC 833 was
2 mM. C6-NBD-GlcCer in the basolateral medium was about 5% of
Implications of Short-Chain Lipid Translocationthe total. C6-NBD-GlcCer synthesis was 1.3 6 0.2 3 control (verap-
amil), 1.5 6 0.1 3 control (PSC 833), and 0.6 6 0.1 3 control (energy by MDR1 Pgp for Studies on Intracellular
depletion). All data are from two experiments in duplicate (n 5 4). Lipid Transport
Structure: G, glucose; NBD, fluorescent group. Short-chain lipid analogs have been widely applied to
study the topology of synthesis and the intracellular
transport of membrane lipids (see Pagano, 1990; Trotter
the outer leaflet (Smit et al., 1993), experimental evi- and Voelker, 1994; van Helvoort and van Meer, 1995).
dence has been provided that mdr2 Pgp can translocate Our present finding (Figures 4 and 6) that newly synthe-
the PC analog C6-NBD-PC across membranes (Ruetz sized C6-NBD-GlcCer, C6-GlcCer, and C8C8-GlcCer can
and Gros, 1994, 1995) and that the human homolog reach the cell surface by the action of MDR1 Pgp re-
MDR3 Pgp can translocate natural PC (Smith et al., quires a reassessment of studies in which transport of
1994). In the present study, we have devised a much these lipids to the cell surface at 378C has been dis-
simpler assay for the translocation activity of MDR3 Pgp cussed in terms of vesicular traffic (Lipsky and Pagano,
that will allow systematic testing of inhibitors and defini- 1985; Karrenbauer et al., 1990; our own studies summa-
tion of substrate specificity. At 158C, where vesicular rized in van der Bijl et al. [1996]).
lipid transport from the Golgi to the cell surface is inhib- Our interpretation that the preferential delivery of C6-
ited, first, cells transfected with MDR3 but not control NBD-GlcCer over C6-NBD-SM to the apical surface of
cells exposed intracellularly synthesized C6-NBD-[3H]PC epithelial cells might be due to lipid sorting in a vesicular
on the cell surface (Figure 2); second, translocation was pathway (van Meer et al., 1987) is compatible with the
limited to the apical surface (Figure 2), where the MDR3 observation that C6-NBD-GlcCer can translocate to-
Pgp was located (Figure 1); third, transport was sensitive wards the lumenal leaflet of the Golgi membrane (Burger
to the MDR inhibitor verapamil and was energy-depen- et al., 1996) and reach the cell surface on the inside of
dent (Table 1), showing that MDR3 Pgp is not the puta- carrier vesicles (see van Helvoort and van Meer, 1995).
tive energy-independent PC translocator in the bile ca- However, the higher concentration of C6-NBD-GlcCer
nalicular membrane (Berr et al., 1993); and fourth, on the apical surface can also be explained by the fact
translocation by the MDR3 Pgp was selective for C6- that C6-NBD-GlcCer is a substrate for MDR1 Pgp (Figure
NBD-PC. A lipid with the same backbone, C6-NBD-PE 4) and that MDR1 Pgp is exclusively present in apical
(Figure 2), and a lipid with the same headgroup, C6-NBD- membranes (Gros and Buschman, 1993). This would not
SM (Figure 4), were not translocated. The specificity of apply to C6-NBD-SM, since it has no access to the MDR
MDR3 Pgp is even more stringent since, as well, a PC Pgp (Figure 4). In preliminary experiments, transport of
with shorter acyl chains C8C8-PC was hardly translo- C6-NBD-lipids to the apical surface of MDCK cells
cated (Figure 3). Possibly, this PC was not inserted into was reduced by MDR inhibitors, while transport of
the membrane well enough to be recognized by the a-hydroxy-C6-sphingolipids (van derBijl et al., 1996) was
MDR3 Pgp. Each lipid must have been able to reach the virtually unaffected (K. N. J. Burger and G. van Meer,
inner leaflet of the plasma membrane, since all were unpublished data). To define the mechanism of lipid
sorting in epithelial cells, it must be determined whethertranslocated by MDR1 Pgp (Figures 2–4).
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Figure 6. Translocation of [14C]C6-GlcCer and [3H]C8C8-GlcCer across the Apical Plasma Membrane of MDR1-Transfected Cells
Cells were incubated for 3 hr at 158C with [14C]C6-ceramide or [3H]C8C8-ceramide. GlcCer (shaded bars) and SM (solid bars) in media and cells
were quantitated as described in Experimental Procedures. The MDR1 inhibitor PSC 833 was used at 2 mM. Synthesis was 1,500 dpm for
[14C]C6-GlcCer and 40,000 dpm for [3H]C8C8-GlcCer. Data are from two experiments in duplicate. Structure: G, glucose; asterisk, [3H] or
[14C]radiolabel.
endogenous GlcCer is a substrate for MDR1 Pgp, in membrane lipids of very different structure, from a glyc-
erophospholipid like PC to a glycosphingolipid likewhich case the relative contribution of the vesicular and
MDR pathways to the delivery of lipids to each cell GlcCer, brings up the question of whether the transloca-
tion of lipids is a physiological function of these proteins.surface must be defined.
In a second series of studies, short-chain analogs of Endogenous short-chain lipids occur in living cells and
could be substrates for MDR1 Pgp: in the first place, thePS and PE have been inserted into the exoplasmic leaflet
of the plasma membrane of various cell types to study prime example is the bioactive lipid platelet-activating
factor (PAF), which is a C2-PC. The mechanism by whichthe kinetics of ATP-dependent translocation to the inner
leaflet by the aminophospholipid translocator (see De- PAF is secreted at sites of inflammation is unclear, but
translocation across the plasma membrane may be in-vaux and Zachowski, 1994; Menon, 1995; Pomorski et
al., 1996). This is not the MDR1 Pgp (Auland et al., 1994; volved (Prescott et al., 1990; Vallari et al., 1990; Bratton,
1993). Our results (Figure 2) suggest that PAF may be aHanada and Pagano, 1995; Tang et al., 1996). Our finding
that short-chain PE is a substrate for ATP-dependent substrate for both MDR1 and MDR3 Pgp, and especially
from the clinical point of view it will be interesting totranslocation in the opposite direction implies that if
MDR1 Pgp was present in the plasma membrane of the see whether MDR1 or MDR3 Pgp are actually involved
in PAF release. In the second place, a second class ofcells studied, the previous studies have measured the
combined action of both transport systems. lipids with a short-chain at the sn-2 position consists
of oxidatively fragmented membrane phospholipids.
These toxic lipids, mostly PC in which an unsaturatedDoes MDR1 Pgp Translocate Natural Lipids?
Identification of the MDR1 and mdr1a Pgp as flippases acyl chain has been peroxidized and shortened (Tanaka
et al., 1993), have a PAF–like activity (see Heery et al.,or translocators for short-chain analogs of endogenous
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the role of MDR1 and mdr1a Pgp in lipid translocation,
the importance of the latter Pgp for protecting the organ-
ism against xenotoxins has been directly and convinc-
ingly demonstrated (Schinkel et al., 1994; 1995).
Conclusion
The capability of MDR1 Pgp to translocate a wide variety
of short-chain lipid molecules across the plasma mem-
brane may radically change our views on the physiologi-
cal function of the protein. Besides pumping xenotoxins
out of cells, it may serve a function in organizing natural
lipids, be it short-chain or long-chain. Many different
lipid translocation events occur in cellular membranes,
and many of those must be protein-mediated (Menon,
1995). The involvement of the ABC–transporters Pat1
and Pat2 in peroxisomal import of long-chain fatty acids
(Hettema et al., 1996), the present identification of MDR1
and mdr1a Pgp as lipid translocators of broad specific-
ity, and the identification of MDR3 and mdr2 Pgp as
specific translocators of PC suggest that a systematic
assessment of lipid-translocating properties of ABC–
transporters may open a new chapter in the search for
lipid flippases.
Experimental Procedures
Figure 7. Translocation of C6-NBD-PC, -PE, -GlcCer, and -SM Materials
across the Apical Plasma Membrane of mdr1a-Transfected Cells Vincristine, verapamil, and BSA fraction V were purchased from
Cells were incubated for 3 hr at 158C with 25 mM C6-NBD-PA or 5 Sigma (St. Louis, MO). PSC 833 was a gift of Dr. D. Cohen at Sandoz
mM C6-NBD-ceramide as in Figures 2 and 4 (two experiments in (NJ). [Methyl-3H]-choline chloride (3.0 GBq/mmol) was from DuPont
duplicate, n 5 4). In cells treated with brefeldin A (BFA) as in Figure NEN (Dordrecht, The Netherlands) and [2-14C]-ethanolamine hydro-
4, transport of C6-NBD-GlcCer was identical to that in untreated chloride (2.1 GBq/mmol) from Amersham (Little Chalfont, UK). Ge-
cells. Synthesis of C6-NBD-lipid/filter: GlcCer, 16 6 2 pmol; SM, neticin (G418) and cell culture media were from Gibco (Paisley, UK),
36 6 5 pmol; PC, 12 6 1 pmol; PE, 7 6 1 pmol. Brefeldin A did not and phenylmethanesulfonyl fluoride and silica thin-layerchromatog-
affect synthesis of C6-NBD-GlcCer but increased synthesis of C6- raphy (TLC) plates were from Merck (Darmstadt, Federal Republic
NBD-SM 3.1 times. For lipid structures see Figures 2 and 4. of Germany). Organic solvents were from Riedel-de Hae¨n (Seelze,
Federal Republic of Germany).
1-Hexadecanoyl-2-(C6-NBD)-sn-glycero-3-phosphocholine (C6-
1995). MDR1 Pgp may assist in their removal from the NBD-PC) and C8C8-PA were from Avanti (Alabaster, AL). C6-NBD-
body by translocation across the apical membranes of phosphatidic acid was prepared from C6-NBD-PC using phospholi-
pase D (van Helvoort et al., 1994). C6-NBD-ceramide was fromthe cells lining the gastrointestinal and urinary tracts.
Molecular Probes (Eugene, OR). [1-14C]C6-ceramide (0.15 MBq/In the third place, possibly, lysophospholipids are also
mmol) was synthesized as before (van der Bijl et al., 1996). [2,3-substrates for Pgps. Lyso-PC displays a half-time of 3H]Octanoyl-D-erythro-C8-sphingosine (C8C8-ceramide; 1.85 GBq/
translocation across liposomes and plasma membranes mmol) synthesized as in Karrenbauer et al. (1990) was a gift of Dr.
of hours (see Bhamidipati and Hamilton, 1995). During F. Wieland (Heidelberg, Federal Republic of Germany).
signal transduction, translocation may serve to remove
Cellsnewly generated lysophospholipids, lyso-PA and lyso-
LLC-PK1 pig kidney epithelial cells were obtained from AmericanPC, from the inner leaflet of the plasma membrane.
Type Culture Collection (Rockville, MD) and cultured (mycoplasma-Fourth, finally, short-chain glycosphingolipids have
free) in M199 medium supplemented with 10% fetal calf serum as
been reported to occur in cultured cells (Sandvig et al., described (Schinkel et al., 1995). For experiments, 2 3 106 cells were
1994). Their physiological relevance ispresently unclear. seeded on 4.7 cm2 filters, 0.4 mm pore diameter, glued to the bottom
It seems unlikely that MDR1 and mdr1a Pgp can trans- of plastic rings (“Transwell,” Costar, Cambridge, MA) so as to be
able to separate apical and basolateral medium (van Meer et al.,locate endogenous long-chain membrane lipids. Al-
1987), and grown as monolayers for 4 days.though both mouse mdr2 (Ruetz and Gros, 1994, 1995)
and mdr1a Pgp (Figure 7) can translocate C6-NBD-PC,
Transfection with Human MDR1 and MDR3mdr1a Pgp appears unable to compensate for the ab-
and Mouse mdr1a
sence of mdr2 Pgp in transporting PC into the bile of Human MDR1 and mouse mdr1a cDNA were transfected as the
the mdr2 knock-out mouse (Smit et al., 1993). Further- plasmids pFRCMVMDR1.1 and pFRCMVmdr1a into LLC-PK1 cells
as described (Schinkel et al., 1995). Mouse mdr1a (mdr3-S) cDNAmore, the occurrence of both a broad-specificity translo-
was a gift of Dr. P. Gros (McGill University, Montreal, Canada). Thecase and the aminophospholipid translocase (Devaux
transfectants were maintained at 640 nM vincristine selection.and Zachowski, 1994) working in opposite directions in
A mixed cDNA/genomic DNA MDR3 gene (Smit et al., 1994) wasone membrane would lead to a futile cycle of utilizing
cloned into the mammalian expression vector pRc/RSV (Invitrogen,
ATP to pump PE back and forth. Of course, it remains Leek, The Netherlands). The resulting construct (10 mg) with 10 mg
possible that these translocators are differentially and of salmon sperm carrier DNA was used to transfect LLC-PK1 cells by
calcium phosphate coprecipitation. Transfected cells were selectedcoordinately regulated(see Gaffet et al., 1995). Whatever
Cell
516
with G418 (0.8 mg/ml). Colonies that arose were picked after 3 weeks detected by fluorography and quantified as before (van der Bijl et
al., 1996).and expanded, and MDR3 Pgp expression was determined by pro-
tein blot analysis of cell lysates using MDR3 Pgp-specific polyclonal
antiserum AVLCL2 (Smit et al., 1994). Mock-transfected cells did Acknowledgments
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with an empty pRc/RSV vector did not express MDR3 Pgp. A stable Correspondence should be addressed to G. v. M. We are grateful
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